China's Pharmaceutical Leap: A Game Changer or a Warning Sign?
China has made significant strides in pharmaceutical innovation, with domestically produced novel drugs accounting for over 80% of market approvals in the first half of the year.
The government's emphasis on "systemic leap" in quality suggests a concerted effort to reduce reliance on foreign imports and establish the country as a major player in the global biotech industry.